Skip to main content
logo
Emmaus Life Sciences, Inc. (EMMA)
OTCMKTS · Delayed Price · Currency is USD
0.0678
+0.00611 (9.90%)
At close: Sep 25, 2026

Emmaus Life Sciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
41161382
Market Cap Growth
516.34%52.94%-91.23%-52.02%-84.34%36.67%
Enterprise Value
3232323942103
Last Close Price
0.060.010.010.100.261.67

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-5.505.505.504.34-
PS Ratio
0.280.070.030.210.704.00
PB Ratio
-0.07-0.01-0.01-0.13-0.38-3.84

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
2.062.591.911.312.274.99
EV/EBITDA Ratio
6.47119.35-10.85--
EV/EBIT Ratio
7.04139.50-10.95--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.46-0.51-0.58-0.70-0.90-1.04
Debt / EBITDA Ratio
6.1642.28-7.05--
Net Debt / Equity Ratio
-0.42-0.48-0.56-0.65-0.84-0.94
Net Debt / EBITDA Ratio
6.01112.71-16.878.64-4.41-3.32
Net Debt / FCF Ratio
6.99-2536.00-13.74-20.31-5.65-15.17
Asset Turnover
0.780.550.570.710.350.36
Inventory Turnover
0.690.540.720.660.760.58
Quick Ratio
0.050.070.060.130.040.09
Current Ratio
0.090.110.110.190.120.25
Return on Assets (ROA)
14.32%0.64%-4.03%5.31%-7.84%-6.59%
Return on Capital Employed (ROCE)
-9.10%-0.50%4.70%-13.40%108.00%-31.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-139.10%-902.38%-1188.71%-60.31%-82.36%-19.36%
FCF Yield
91.57%-1.44%-423.32%-24.56%-39.53%-1.61%
Buyback Yield / Dilution
-5.22%-1.27%-19.07%-7.41%-0.38%-0.73%